Search company, investor...


Founded Year



Grant - II | Alive

Total Raised


Last Raised

$140K | 17 yrs ago

About SimuGen

Developer of predictive toxicology products. The company is a drug discovery pharmacogenomics company focused on predicting human safety earlier. It combines groundbreaking human cell culture and genomic modelling to produce high throughput screens for use alongside other early ADME testing.

Headquarters Location

83 Victoria Street

London, England, SW1H 0HW,

United Kingdom

44 203 326 4283

Missing: SimuGen's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: SimuGen's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

SimuGen Frequently Asked Questions (FAQ)

  • When was SimuGen founded?

    SimuGen was founded in 2005.

  • Where is SimuGen's headquarters?

    SimuGen's headquarters is located at 83 Victoria Street, London.

  • What is SimuGen's latest funding round?

    SimuGen's latest funding round is Grant - II.

  • How much did SimuGen raise?

    SimuGen raised a total of $280K.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.